402469-32-3

Upstream product

• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 402469-51-6 1-[4-(t-butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-pentan-3-on 
• 458-36-6 trans-coniferyl aldehyde 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 290820-47-2 (2E)-3-[4-[[tert-butyldimethylsilyl]oxy]-3-methoxyphenyl]acrylaldehyde 
• 402469-50-5 1-[4-(tert-butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-pentan-3-ol 

Downstream Products

• 402469-33-4 5-[4-(t-butyl-dimethyl-silanyloxy)-3-methoxyphenyl]-3-ethyl-pentanic Acid Ethyl Ester 
• 402469-34-5 5-[4-(tert-butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-3-ethyl-pentanoic acid phenethyl-amide 
• 402469-35-6 5-[4-(tert-butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-3-ethyl-pentanethioic acid phenethyl-amide 

Relevant academic research and scientific papers

Chain-branched acyclic phenethylthiocarbamates as vanilloid receptor antagonists

A series of acyclic phenethylthiocarbamate derivatives have been synthesized, and their antagonist effect against vanilloid receptor tested. Chain branching led to a significant change in antagonist activity of the parent molecule. Ethyl-branched 1e showe

Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same

The present invention relates to an antagonist against vanilloid receptor and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain, acute pain, chronic pain, neuropathic pain, post-opera